Cargando…
Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors
Glioblastoma multiforme (GBM) remains refractory to conventional therapy. CD133+ GBM cells have been recently isolated and characterized as chemo-/radio-resistant tumor-initiating cells and are hypothesized to be responsible for post-treatment recurrence. In order to explore the molecular properties...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Springer US
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705704/ https://www.ncbi.nlm.nih.gov/pubmed/19468690 http://dx.doi.org/10.1007/s11060-009-9919-z |
_version_ | 1782169019677147136 |
---|---|
author | Liu, Qinghai Nguyen, David H. Dong, Qinghua Shitaku, Peter Chung, Kenneth Liu, On Ying Tso, Jonathan L. Liu, Jason Y. Konkankit, Veerauo Cloughesy, Timothy F. Mischel, Paul S. Lane, Timothy F. Liau, Linda M. Nelson, Stanley F. Tso, Cho-Lea |
author_facet | Liu, Qinghai Nguyen, David H. Dong, Qinghua Shitaku, Peter Chung, Kenneth Liu, On Ying Tso, Jonathan L. Liu, Jason Y. Konkankit, Veerauo Cloughesy, Timothy F. Mischel, Paul S. Lane, Timothy F. Liau, Linda M. Nelson, Stanley F. Tso, Cho-Lea |
author_sort | Liu, Qinghai |
collection | PubMed |
description | Glioblastoma multiforme (GBM) remains refractory to conventional therapy. CD133+ GBM cells have been recently isolated and characterized as chemo-/radio-resistant tumor-initiating cells and are hypothesized to be responsible for post-treatment recurrence. In order to explore the molecular properties of tumorigenic CD133+ GBM cells that resist treatment, we isolated CD133+ GBM cells from tumors that are recurrent and have previously received chemo-/radio-therapy. We found that the purified CD133+ GBM cells sorted from the CD133+ GBM spheres express SOX2 and CD44 and are capable of clonal self-renewal and dividing to produce fast-growing CD133− progeny, which form the major cell population within GBM spheres. Intracranial injection of purified CD133+, not CD133− GBM daughter cells, can lead to the development of YKL-40+ infiltrating tumors that display hypervascularity and pseudopalisading necrosis-like features in mouse brain. The molecular profile of purified CD133+ GBM cells revealed characteristics of neuroectoderm-like cells, expressing both radial glial and neural crest cell developmental genes, and portraying a slow-growing, non-differentiated, polarized/migratory, astrogliogenic, and chondrogenic phenotype. These data suggest that at least a subset of treated and recurrent GBM tumors may be seeded by CD133+ GBM cells with neural and mesenchymal properties. The data also imply that CD133+ GBM cells may be clinically indolent/quiescent prior to undergoing proliferative cell division (PCD) to produce CD133− GBM effector progeny. Identifying intrinsic and extrinsic cues, which promote CD133+ GBM cell self-renewal and PCD to support ongoing tumor regeneration may highlight novel therapeutic strategies to greatly diminish the recurrence rate of GBM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-009-9919-z) contains supplementary material, which is available to authorized users. |
format | Text |
id | pubmed-2705704 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-27057042009-07-07 Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors Liu, Qinghai Nguyen, David H. Dong, Qinghua Shitaku, Peter Chung, Kenneth Liu, On Ying Tso, Jonathan L. Liu, Jason Y. Konkankit, Veerauo Cloughesy, Timothy F. Mischel, Paul S. Lane, Timothy F. Liau, Linda M. Nelson, Stanley F. Tso, Cho-Lea J Neurooncol Priority Report Glioblastoma multiforme (GBM) remains refractory to conventional therapy. CD133+ GBM cells have been recently isolated and characterized as chemo-/radio-resistant tumor-initiating cells and are hypothesized to be responsible for post-treatment recurrence. In order to explore the molecular properties of tumorigenic CD133+ GBM cells that resist treatment, we isolated CD133+ GBM cells from tumors that are recurrent and have previously received chemo-/radio-therapy. We found that the purified CD133+ GBM cells sorted from the CD133+ GBM spheres express SOX2 and CD44 and are capable of clonal self-renewal and dividing to produce fast-growing CD133− progeny, which form the major cell population within GBM spheres. Intracranial injection of purified CD133+, not CD133− GBM daughter cells, can lead to the development of YKL-40+ infiltrating tumors that display hypervascularity and pseudopalisading necrosis-like features in mouse brain. The molecular profile of purified CD133+ GBM cells revealed characteristics of neuroectoderm-like cells, expressing both radial glial and neural crest cell developmental genes, and portraying a slow-growing, non-differentiated, polarized/migratory, astrogliogenic, and chondrogenic phenotype. These data suggest that at least a subset of treated and recurrent GBM tumors may be seeded by CD133+ GBM cells with neural and mesenchymal properties. The data also imply that CD133+ GBM cells may be clinically indolent/quiescent prior to undergoing proliferative cell division (PCD) to produce CD133− GBM effector progeny. Identifying intrinsic and extrinsic cues, which promote CD133+ GBM cell self-renewal and PCD to support ongoing tumor regeneration may highlight novel therapeutic strategies to greatly diminish the recurrence rate of GBM. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s11060-009-9919-z) contains supplementary material, which is available to authorized users. Springer US 2009-05-26 2009-08 /pmc/articles/PMC2705704/ /pubmed/19468690 http://dx.doi.org/10.1007/s11060-009-9919-z Text en © The Author(s) 2009 |
spellingShingle | Priority Report Liu, Qinghai Nguyen, David H. Dong, Qinghua Shitaku, Peter Chung, Kenneth Liu, On Ying Tso, Jonathan L. Liu, Jason Y. Konkankit, Veerauo Cloughesy, Timothy F. Mischel, Paul S. Lane, Timothy F. Liau, Linda M. Nelson, Stanley F. Tso, Cho-Lea Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors |
title | Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors |
title_full | Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors |
title_fullStr | Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors |
title_full_unstemmed | Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors |
title_short | Molecular properties of CD133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors |
title_sort | molecular properties of cd133+ glioblastoma stem cells derived from treatment-refractory recurrent brain tumors |
topic | Priority Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2705704/ https://www.ncbi.nlm.nih.gov/pubmed/19468690 http://dx.doi.org/10.1007/s11060-009-9919-z |
work_keys_str_mv | AT liuqinghai molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT nguyendavidh molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT dongqinghua molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT shitakupeter molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT chungkenneth molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT liuonying molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT tsojonathanl molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT liujasony molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT konkankitveerauo molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT cloughesytimothyf molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT mischelpauls molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT lanetimothyf molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT liaulindam molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT nelsonstanleyf molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors AT tsocholea molecularpropertiesofcd133glioblastomastemcellsderivedfromtreatmentrefractoryrecurrentbraintumors |